Correspondingly, flow cytometry analysis and immunohistochemistry staining of pleural cancer nodules both demonstrated an increase in the CD86+ subset and a decrease in CD206+ subset (Fig. 2C, D, K and Figure S2C-E). This evidence concerns the gene MRC1 and pleural cancer.